Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.18B |
| 2 |
Medtronic
MDT
|
+$2.06B |
| 3 |
Microsoft
MSFT
|
+$1.61B |
| 4 |
Procter & Gamble
PG
|
+$1.47B |
| 5 |
UBS Group
UBS
|
+$1.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.42B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$2.34B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$930M |
| 4 |
Apple
AAPL
|
+$637M |
| 5 |
SWY
SAFEWAY INC
SWY
|
+$620M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.67% |
| 2 | Technology | 13.6% |
| 3 | Financials | 13.57% |
| 4 | Industrials | 10.71% |
| 5 | Consumer Discretionary | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CALY
2176
Callaway Golf Company
CALY
$3.14B
| $28.6M | ﹤0.01% |
3,000,435
+178,847
| +6% | +$1.52M |
|
|
WIBC
2177
DELISTED
WILSHIRE BANCORP INC
WIBC
| $28.6M | ﹤0.01% |
2,867,522
+135,518
| +5% | +$1.31M |
|
2178
Quantum Corp
QMCO
$474M
| $28.4M | ﹤0.01% |
111,000
+14,525
| +15% | +$3.83M |
|
|
FMI
2179
DELISTED
Foundation Medicine, Inc.
FMI
| $28.3M | ﹤0.01% |
587,411
-40,822
| -6% | -$1.85M |
|
2180
Central Garden & Pet Co Class A
CENTA
$2.44B
| $28.1M | ﹤0.01% |
3,306,875
+156,066
| +5% | +$1.25M |
|
|
GTI
2181
DELISTED
GRAFTECH INTERNATIONAL LTD
GTI
| $28.1M | ﹤0.01% |
7,216,618
+351,729
| +5% | +$1.41M |
|
2182
Douglas Dynamics
PLOW
$1.02B
| $28M | ﹤0.01% |
1,228,046
+196,358
| +19% | +$4.25M |
|
|
MIG
2183
DELISTED
MEADOWBROOK INSURANCE GRP INC
MIG
| $28M | ﹤0.01% |
3,296,267
+205,370
| +7% | +$1.72M |
|
|
PGI
2184
DELISTED
PREMIERE GLOBAL SERVICES, INC.
PGI
| $28M | ﹤0.01% |
2,928,543
+260,172
| +10% | +$2.48M |
|
|
TESO
2185
DELISTED
Tesco Corp
TESO
| $27.9M | ﹤0.01% |
2,455,706
+269,590
| +12% | +$2.95M |
|
2186
Sabesp
SBS
$18.7B
| $27.9M | ﹤0.01% |
27,311,852
-459,812
| -2% | -$492K |
|
2187
Stagwell
STGW
$2.24B
| $27.8M | ﹤0.01% |
981,807
+171,674
| +21% | +$4.33M |
|
2188
DHI Group
DHX
$173M
| $27.8M | ﹤0.01% |
3,115,299
+150,964
| +5% | +$1.37M |
|
2189
REX American Resources
REX
$1.41B
| $27.8M | ﹤0.01% |
2,740,746
+533,772
| +24% | +$5.13M |
|
|
FOLD
2190
DELISTED
Amicus Therapeutics
FOLD
| $27.8M | ﹤0.01% |
2,550,728
+173,039
| +7% | +$1.53M |
|
|
ASEI
2191
DELISTED
AMER SCIENCE & ENGR INC.
ASEI
| $27.7M | ﹤0.01% |
566,143
+43,637
| +8% | +$2.2M |
|
2192
Melco Resorts & Entertainment
MLCO
$2.14B
| $27.6M | ﹤0.01% |
+1,287,000
| New | +$30.8M |
|
2193
Rexford Industrial Realty
REXR
$8.19B
| $27.6M | ﹤0.01% |
1,744,010
+582,567
| +50% | +$9.33M |
|
|
PRFT
2194
DELISTED
Perficient Inc
PRFT
| $27.6M | ﹤0.01% |
1,332,183
+54,326
| +4% | +$1.05M |
|
2195
Theravance Biopharma
TBPH
$877M
| $27.4M | ﹤0.01% |
1,579,867
+93,842
| +6% | +$1.72M |
|
|
PES
2196
DELISTED
Pioneer Energy Services Corp.
PES
| $27.4M | ﹤0.01% |
5,049,695
-1,051,257
| -17% | -$5.24M |
|
|
NILE
2197
DELISTED
Blue Nile, Inc.
NILE
| $27.3M | ﹤0.01% |
858,504
+12,518
| +1% | +$392K |
|
2198
Anika Therapeutics
ANIK
$287M
| $27.3M | ﹤0.01% |
662,240
+9,391
| +1% | +$380K |
|
2199
Harte-Hanks
HHS
$16.9M
| $27.2M | ﹤0.01% |
348,563
+37,866
| +12% | +$2.93M |
|
|
LBY
2200
DELISTED
Libbey, Inc.
LBY
| $27.2M | ﹤0.01% |
680,569
+30,679
| +5% | +$1.08M |
|
Similar funds
Vanguard Group's Q1 2015 Portfolio in Review
As of Q1 2015, Vanguard Group held 4,228 positions worth $1.47T, up 6.2% from $1.39T the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Vanguard Group deployed $66B of net new capital in Q1 2015, opening 181 new positions and adding to 3,456 existing holdings. Its largest new stake was UBS Group: 57,940,325 shares worth $1.09B.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $637M trimmed.
- Vanguard Group's largest Q1 2015 buy was UBS Group: 57,940,325 shares worth $1.09B.
- Vanguard Group added most to Allergan plc in Q1 2015, an estimated $2.18B increase.
- Vanguard Group's biggest Q1 2015 reduction was Apple, cutting an estimated $637M.
- Vanguard Group fully exited Allergan Inc in Q1 2015, selling an estimated $3.42B.
- Vanguard Group's ten largest holdings make up 12% of its $1.47T portfolio in Q1 2015.
- Vanguard Group opened 181 new positions and closed 75 in Q1 2015.
- Vanguard Group's portfolio value rose 6.2% quarter-over-quarter to $1.47T.
Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.